title: Therapy of steroid-refractory acute GVHD with CD52 antibody alemtuzumab is effective.
authors.affiliation: Division for Stem Cell Transplantation and Immunotherapy, Second Department of Medicine, Kiel, Germany.
authors.forename: N
authors.initials: N
authors.lastname: Schub
authors.forename: A
authors.initials: A
authors.lastname: Günther
authors.forename: A
authors.initials: A
authors.lastname: Schrauder
authors.forename: A
authors.initials: A
authors.lastname: Claviez
authors.forename: C
authors.initials: C
authors.lastname: Ehlert
authors.forename: M
authors.initials: M
authors.lastname: Gramatzki
authors.forename: R
authors.initials: R
authors.lastname: Repp